Epilepsy Drugs Market 2017: USD 5.5 Billion by the year end of 2021

"Epilepsy Drugs Market 2017 adds MarketReportsOnline.com: Global Demand, Growth Potential & Opportunity Outlook 2021" report to its research store.

Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.

The Research Report Titled “Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021” examines the market, competitive landscape and trends of the Global Epilepsy Drug Market. This report analyzes market data and provides a better understanding of Epilepsy Drugs sales value and demand in the Global Market. Market outlook in value terms for the forecasted period for epilepsy drugs market has been detailed in the report. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Epilpesy Drugs Market.

Company Coverage of Epilepsy Drugs Market: UCB, EISAI, Pfizer, Sanofi And Lundbeck

Complete report on Epilepsy Drugs market spread across 80 pages providing 5 company profiles with 6 tables and 23 figures is now available at http://www.marketreportsonline.com/577631.html.

Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.

Vimpat is the undisputed leading drug of Global Epilepsy Drugs Market. It has a market share of nearly 22% in 2016 and is expected that Vimpat will gain its momentum till the forecasting period. Keppra was the second highest market share taker with more than 19% share in 2016 but the prospect of this drug will change due to the patent expiration in 2018 and its share decline to XX% by 2021. It is expected that Lamictal will be second leading drug with nearly XX% share by 2021. Onfi hold the third highest share of the Epilepsy Drugs market, being followed by Depakine by the year end of 2021.

Purchase  a copy of this Epilepsy Drugs Market research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=577631.

The report concludes with the profiles of major players in the Epilepsy Drugs Market such as UCB, EISAI, Pfizer, Sanofi and Lundbeck. The major market players are evaluated on various parameters such as company overview and latest development and trends in the Epilepsy Drugs Market

Key Topics Covered in the Report
Worldwide Epilepsy Drugs Market Analysis (2013 – 2021)
Worldwide Epilepsy Drugs Market Share (2013 – 2021)
Worldwide Epilepsy Drugs Brand Market Performance (2013 – 2021)
Epilepsy Drugs Market – Major Deal Types
Key Companies Analysis
Key Drivers and Inhibitors of the Epilepsy Drugs Market

Key Epilepsy Drugs Covered in the Report are as follows: Vimpat (Lacosamide), Keppra (Levetiracetam), Briviact (Brivaracetam), Lamictal (Lamotrigine), Neurontin (Gabapentin), Depakine (Sodium Valproate), Sabril (Vigabatrin), Onfi (Clobazam), Fycompa (Perampanel), Inovelon/Banzel (Rufinamide), Zonegran (Zonisamide), Zebinix (Eslicarbazepine Acetate)

Key Topics Covered:
Executive Summary
Worldwide – Epilepsy Drugs Market Analysis (2013 – 2021)
Worldwide – Epilepsy Drugs Market Share (2013 – 2021)
Key Drivers and Inhibitors of the Epilepsy Drugs Market
Worldwide – Epilepsy Drugs Brand Market Performance (2013 – 2021)
Epilepsy Drugs Market – Major Deal Types
Key Companies Analysis

Browse All Latest Pharmaceuticals Market Research Reports at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: [email protected]

Posted by [email protected] [email protected] on Tuesday March 21 2017, 8:15 AM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0